Metformin can reduce the rate of cognitive decline, study suggests

A group of researchers based at the Garvan Institute of Medical Research (Sydney, Australia) and the Centre for Healthy Brain Ageing, University of New South Wales (Sydney, Australia) has identified that the common Type 2 diabetes drug metformin may reduce the rate of cognitive decline. The authors of the study, published in Diabetes Care, suggest that metformin could be repurposed to treat individuals at high risk of dementia. “As they age, people living with Type 2 diabetes have a staggering 60% risk of developing dementia, a devastating condition that impacts thinking, behavior, the ability to perform everyday tasks and the...